[HTML][HTML] Radiolabelling of nanomaterials for medical imaging and therapy
Nanomaterials offer unique physical, chemical and biological properties of interest for
medical imaging and therapy. Over the last two decades, there has been an increasing effort …
medical imaging and therapy. Over the last two decades, there has been an increasing effort …
Radioactive transition metals for imaging and therapy
E Boros, AB Packard - Chemical reviews, 2018 - ACS Publications
Nuclear medicine is composed of two complementary areas, imaging and therapy. Positron
emission tomography (PET) and single-photon imaging, including single-photon emission …
emission tomography (PET) and single-photon imaging, including single-photon emission …
The Na+/I− Symporter (NIS): Mechanism and Medical Impact
C Portulano, M Paroder-Belenitsky… - Endocrine …, 2014 - academic.oup.com
Abstract The Na+/I− symporter (NIS) is the plasma membrane glycoprotein that mediates
active I− transport in the thyroid and other tissues, such as salivary glands, stomach …
active I− transport in the thyroid and other tissues, such as salivary glands, stomach …
[HTML][HTML] Rhenium-188 labeled radiopharmaceuticals: current clinical applications in oncology and promising perspectives
N Lepareur, F Lacœuille, C Bouvry, F Hindré… - Frontiers in …, 2019 - frontiersin.org
Rhenium-188 (188Re) is a high energy beta-emitting radioisotope with a short 16.9 h
physical half-life, which has been shown to be a very attractive candidate for use in …
physical half-life, which has been shown to be a very attractive candidate for use in …
Sodium iodide symporter: its role in nuclear medicine
JK Chung - Journal of nuclear medicine, 2002 - Soc Nuclear Med
Thyroid iodide uptake is basic to the clinical applications of radioiodine. Iodide uptake
occurs across the membrane of the thyroid follicular cells through an active transporter …
occurs across the membrane of the thyroid follicular cells through an active transporter …
A perspective view of sodium iodide symporter research and its clinical implications
G Riesco-Eizaguirre… - European Journal of …, 2006 - academic.oup.com
The sodium iodide symporter (NIS) is an intrinsic plasma membrane protein that mediates
active iodide transport into the thyroid gland and into several extrathyroidal tissues, in …
active iodide transport into the thyroid gland and into several extrathyroidal tissues, in …
ICRP publication 137: occupational intakes of radionuclides: part 3
F Paquet, MR Bailey, RW Leggett… - Annals of the …, 2017 - journals.sagepub.com
The 2007 Recommendations of the International Commission on Radiological Protection
(ICRP, 2007) introduced changes that affect the calculation of effective dose, and implied a …
(ICRP, 2007) introduced changes that affect the calculation of effective dose, and implied a …
The sodium iodide symporter: its pathophysiological and therapeutic implications
C Spitzweg, JC Morris - Clinical endocrinology, 2002 - Wiley Online Library
The sodium iodide symporter (NIS) is an intrinsic plasma membrane protein that mediates
the active transport of iodide in the thyroid gland and a number of extrathyroidal tissues, in …
the active transport of iodide in the thyroid gland and a number of extrathyroidal tissues, in …
Anion selectivity by the sodium iodide symporter
J Van Sande, C Massart, R Beauwens… - …, 2003 - academic.oup.com
The iodide transporter of the thyroid (NIS) has been cloned by the group of Carrasco. The
NIS-mediated transport was studied by electrophysiological methods in NIS-expressing …
NIS-mediated transport was studied by electrophysiological methods in NIS-expressing …
Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter–expressing tissues in vivo
LS Zuckier, O Dohan, Y Li, CJ Chang… - Journal of Nuclear …, 2004 - Soc Nuclear Med
Pertechnetate (as 99mTcO4−), 123I−, and 131I− have a long and successful history of use in
the diagnosis and therapy of thyroid cancer, with uptake into thyroid tissue mediated by the …
the diagnosis and therapy of thyroid cancer, with uptake into thyroid tissue mediated by the …